{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:03:33Z","timestamp":1751414613499},"reference-count":18,"publisher":"Japan Society for Clinical Immunology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2177\/jsci.38.86","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T18:07:04Z","timestamp":1432577224000},"page":"86-92","source":"Crossref","is-referenced-by-count":3,"title":["Mesenchymal stem cells for the treatment and repair of inflammatory arthritis"],"prefix":"10.2177","volume":"38","author":[{"given":"Yoshiya","family":"TANAKA","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshiro","family":"SONOMOTO","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"KONDO","sequence":"additional","affiliation":[{"name":"Pharmacology Research Laboratories I, Research Division, Mitsubishi-Tanabe Pharma Corporation"},{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"OSHITA","sequence":"additional","affiliation":[{"name":"Pharmacology Research Laboratories I, Research Division, Mitsubishi-Tanabe Pharma Corporation"},{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Mei","family":"ZHANG","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"FUKUYO","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"YAMAOKA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine"},{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Pittenger, M.F., et al.: Multilineage potential of adult human mesenchymal stem cells. Science<\/i>. 284<\/b>: 143-147, 1999."},{"key":"2","unstructured":"2) Uccelli, A., et al.: Mesenchymal stem cells in health and disease. Nat Rev Immunol<\/i>. 8<\/b>: 726-736, 2008."},{"key":"3","unstructured":"3) Le Blanc, K., et al.: Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet<\/i>. 371<\/b>: 1579-1586, 2008."},{"key":"4","unstructured":"4) Sun, L., et al.: Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells<\/i>. 27<\/b>: 1421-1432, 2009."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tyndall, A., Houssiau, F.A.: Mesenchymal stem cells in the treatment of autoimmune diseases. Ann Rheum Dis<\/i>. 69<\/b>: 1413-1414, 2010.","DOI":"10.1136\/ard.2010.132639"},{"key":"6","unstructured":"6) Sonomoto, K., et al.: IL-1\u03b2 induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt5a\/Ror2 pathway. Arthritis Rheum<\/i>. 64<\/b>: 3355-3363, 2012."},{"key":"7","unstructured":"7) Sonomoto, K., et al.: The non-canonical wnt5a\/rors signaling pathway in bone metabolism. Inflammation and Regeneration<\/i> (in press)."},{"key":"8","unstructured":"8) Fukuyo, S., et al.: IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3-dependent. Rheumatology<\/i>. 53<\/b>: 1282-1290, 2014."},{"key":"9","unstructured":"9) Oshita, K., et al.: Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. Arthritis Rheum<\/i>. 63<\/b>: 1658-1667, 2011."},{"key":"10","unstructured":"10) Oshita, K., et al.: Regulatory role of mesenchymal stem cells in osteoclast differentiation. Inflammation and Regeneration<\/i>. 33<\/b>: 217-222, 2013."},{"key":"11","unstructured":"11) Kondo, M., et al.: IL-6\/STAT3 signaling pathway contributes to chodrogenic differentiation of human mesenchymal stem cells. Arthritis Rheum<\/i>. (in press)."},{"key":"12","unstructured":"12) Kondo, M., et al.: IL-17 inhibits chondrogenic differentiation of human mesenchymal stem cells. Plos ONE<\/i>. 8<\/b>: e79463, 2013."},{"key":"13","unstructured":"13) Kondo, M., et al.: Acquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditions. Int J Mol Sci<\/i>. 15<\/b>: 21270-21285, 2014."},{"key":"14","unstructured":"14) Zhang, X., et al.: Local delivery of mesenchymal stem cells with poly-lactic-co-glycolic acid nano-fiber scaffold suppress arthritis in rats. Plos ONE<\/i>. 9<\/b>: e114621, 2014."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Aggarwal, S., Pittenger, M.F.: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood<\/i>. 105<\/b>: 1815-1822, 2005.","DOI":"10.1182\/blood-2004-04-1559"},{"key":"16","unstructured":"16) Spaggiari, G.M., et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood<\/i>. 111<\/b>: 1327-1333, 2008."},{"key":"17","unstructured":"17) Sato, K., et al.: Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood<\/i>. 109<\/b>: 228-234, 2007."},{"key":"18","unstructured":"18) Lee, R.H., et al.: Therapeutic factors Secreted by mesenchymal stromal cells and tissue repair. J Cell Biochem<\/i>. 112<\/b>: 3073-3078, 2011."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u9593\u8449\u7cfb\u5e79\u7d30\u80de\u3092\u7528\u3044\u305f\u708e\u75c7\u6027\u95a2\u7bc0\u708e\u306e\u6cbb\u7642\u3068\u518d\u751f"],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T08:17:42Z","timestamp":1498205862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/38\/2\/38_86\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.38.86","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}